First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population

Comment

J Sonek et al. Am J Obstet Gynecol. 2007 Jan.

. 2007 Jan;196(1):e19.

doi: 10.1016/j.ajog.2006.07.016. Epub 2006 Sep 25.

No abstract available

Comment on

First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations.
Prefumo F, Sairam S, Bhide A, Thilaganathan B. Prefumo F, et al. Am J Obstet Gynecol. 2006 Mar;194(3):828-33. doi: 10.1016/j.ajog.2005.09.008. Am J Obstet Gynecol. 2006. PMID: 16522420

First-trimester nuchal translucency, nasal bones, and trisomy 21 in selected and unselected populations.
Prefumo F, Sairam S, Bhide A, Thilaganathan B. Prefumo F, et al. Am J Obstet Gynecol. 2006 Mar;194(3):828-33. doi: 10.1016/j.ajog.2005.09.008. Am J Obstet Gynecol. 2006. PMID: 16522420
Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
Monni G, Zoppi MA, Ibba RM, Floris M, Manca F, Axiana C. Monni G, et al. Croat Med J. 2005 Oct;46(5):786-91. Croat Med J. 2005. PMID: 16158472
What is the role of fetal nasal bone examination in the assessment of risk for trisomy 21 in clinical practice?
Ville Y. Ville Y. Am J Obstet Gynecol. 2006 Jul;195(1):1-3. doi: 10.1016/j.ajog.2006.03.104. Am J Obstet Gynecol. 2006. PMID: 16813740 No abstract available.
Additional first-trimester ultrasound markers.
Sonek J, Nicolaides K. Sonek J, et al. Clin Lab Med. 2010 Sep;30(3):573-92. doi: 10.1016/j.cll.2010.04.004. Clin Lab Med. 2010. PMID: 20638573 Review.
Report on the 11- to 13+6-week ultrasound evaluation as a screening test for trisomy 21 in singleton pregnancies.
Borrell A, Robinson JN, Santolaya-Forgas J. Borrell A, et al. Am J Perinatol. 2009 Nov;26(10):703-10. doi: 10.1055/s-0029-1223281. Epub 2009 Jun 29. Am J Perinatol. 2009. PMID: 19565436 Review.